文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

分娩住院时伴与不伴COVID-19的妇女死产风险——美国,2020年3月至2021年9月

Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization - United States, March 2020-September 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-11-26

美国CDC利用Premier医疗数据库特殊COVID-19发布版,分析2020年3月至2021年9月1,249,634次分娩中,分娩住院时记录COVID-19与死产的关联。结果显示,伴COVID-19分娩的死产率为1.26%,不伴者为0.64%,调整后死产风险升高(aRR=1.90),Delta变异株优势期关联更强(aRR=4.04)。

要点

  • 2020年3月至2021年9月,1,249,634次分娩中死产8,154例(0.65%)。
  • 伴COVID-19分娩死产率1.26%(273/21,653),不伴者0.64%(7,881/1,227,981)。
  • 调整后死产风险aRR=1.90(95%CI 1.69-2.15),Delta优势期aRR=4.04(95%CI 3.28-4.97)。

核心结论

  • 分娩住院时记录COVID-19与死产风险升高相关,Delta变异株优势期关联更强。
  • 实施循证COVID-19预防策略(包括孕前或孕期接种疫苗)对减少COVID-19对死产的影响至关重要。

研究设计与样本

  • 利用Premier医疗数据库特殊COVID-19发布版(PHD-SR)的医院行政数据库进行分析。
  • 纳入2020年3月至2021年9月美国1,249,634次分娩,比较分娩住院时记录COVID-19与不伴COVID-19的死产风险。
  • 分析时段分为Delta变异株优势前(2020年3月至2021年6月)和Delta优势期(2021年7月至9月)。

主要发现

  • 2020年3月至2021年9月,1,249,634次分娩中死产8,154例(0.65%)。
  • 伴COVID-19分娩中死产273例(1.26%),不伴COVID-19分娩中死产7,881例(0.64%)。
  • 2020年3月至2021年9月调整后死产风险aRR=1.90(95%CI 1.69-2.15)。
  • Delta优势前aRR=1.47(95%CI 1.27-1.71),Delta优势期aRR=4.04(95%CI 3.28-4.97)。

临床怎么用

  • 原文结论指出,实施循证COVID-19预防策略(包括孕前或孕期接种疫苗)对减少COVID-19对死产的影响至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pregnant women are at increased risk for severe COVID-19-related illness, and COVID-19 is associated with an increased risk for adverse pregnancy outcomes and maternal and neonatal complications (1-3). To date, studies assessing whether COVID-19 during pregnancy is associated with increased risk for stillbirth have yielded mixed results (2-4). Since the B.1.617.2 (Delta) variant of SARS-CoV-2 (the virus that causes COVID-19) became the predominant circulating variant,* there have been anecdotal reports of increasing rates of stillbirths in women with COVID-19.† CDC used the Premier Healthcare Database Special COVID-19 Release (PHD-SR), a large hospital-based administrative database,§ to assess whether a maternal COVID-19 diagnosis documented at delivery hospitalization was associated with stillbirth during March 2020-September 2021 as well as before and during the period of Delta variant predominance in the United States (March 2020-June 2021 and July-September 2021, respectively). Among 1,249,634 deliveries during March 2020-September 2021, stillbirths were rare (8,154; 0.65%): 273 (1.26%) occurred among 21,653 deliveries to women with COVID-19 documented at the delivery hospitalization, and 7,881 (0.64%) occurred among 1,227,981 deliveries without COVID-19. The adjusted risk for stillbirth was higher in deliveries with COVID-19 compared with deliveries without COVID-19 during March 2020-September 2021 (adjusted relative risk [aRR] = 1.90; 95% CI = 1.69-2.15), including during the pre-Delta (aRR = 1.47; 95% CI = 1.27-1.71) and Delta periods (aRR = 4.04; 95% CI = 3.28-4.97). COVID-19 documented at delivery was associated with increased risk for stillbirth, with a stronger association during the period of Delta variant predominance. Implementing evidence-based COVID-19 prevention strategies, including vaccination before or during pregnancy, is critical to reducing the impact of COVID-19 on stillbirths.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. DeSisto CL, Wallace B, Simeone RM, et al. Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization - United States, March 2020-September 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34818318. doi:10.15585/mmwr.mm7047e1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。